Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema

the long-term control of eczema working group for the HOME initiative

    Research output: Contribution to journalArticlepeer-review

    21 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)1124-1132
    Number of pages9
    JournalJournal of the European Academy of Dermatology and Venereology
    Volume33
    Issue number6
    DOIs
    Publication statusPublished (VoR) - Jun 2019

    Funding

    All authors are members of the Harmonising Outcome Measures for Eczema (HOME) initiative. Dr Barbarot has received research grants from Pierre Fabre Laboratory and Fondation pour la dermatite atopique; personal fees from Bioderma, Laboratoire La Roche Posay, Sanofi-Genzyme, Leo Pharma and Abbvie; and non-financial support from Abbvie, Novartis and Janssen. This study was partially supported by PhD studentship of Laura Howells awarded by the British Skin Foundation [ref: 8016]. The funders had no role in the data collection, interpretation and reporting of this study.

    Fingerprint

    Dive into the research topics of 'Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema'. Together they form a unique fingerprint.

    Cite this